Compensation for the CEOs of large health insurance companies rose modestly and less than overall inflation last year, according to a Modern Healthcare analysis of data the companies submitted to regulators.
Excluding startups Alignment Healthcare, Bright Health Group, Clover Health and Oscar Health, publicly traded health insurance CEOs collectively saw total compensation increase by an average 1.1%, whereas inflation was 6.5%, figures derived from Securities and Exchange Commission filings show. CVS Health CEO Karen Lynch, Cigna Group CEO David Cordani and Humana CEO Bruce Broussard’s compensation all lagged inflation.
UnitedHealth Group CEO Andrew Witty’s compensation grew the most at 13.2%, to $20.8 million, primarily due to larger stock awards. Molina Healthcare CEO Joe Zubretsky trailed with a nearly 11% raise and the highest compensation among large insurers, at $22.1 million. Centene was the only large insurer to reduce CEO compensation in 2022 after Sarah London succeeded the late Michael Neidorff that March.
“The long-term performance of established health insurers has been pretty good. If you're a long-term shareholder in United, Elevance, Molina—it's hard to be upset,” said Ari Gottlieb, an independent healthcare analyst at A2 Strategy Group.
All of the insurtech CEOs experienced large declines in total compensation after they benefited from significant stock awards in 2021 following initial public offerings.